Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-21T11:35:27.469Z Has data issue: false hasContentIssue false

Chapter 72 - Ebola Virus Disease

Published online by Cambridge University Press:  23 July 2018

Rachel L. Chin
Affiliation:
University of California, San Francisco School of Medicine
Bradley W. Frazee
Affiliation:
University of California, San Francisco School of Medicine
Zlatan Coralic
Affiliation:
University of California, San Francisco
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ansumana, R., Jacobsen, K. H., Sahr, F., et al. N. Engl. J. Med. 2015; 372(6): 587–8.Google Scholar
Baize, S., Pannetier, D., Oestereich, L., et al. Emergence of Zaire Ebola virus disease in Guinea. N. Engl. J. Med. 2014; 371(15): 1418–25.CrossRefGoogle ScholarPubMed
Barry, M., Touré, A., Traoré, F. A., et al. Clinical predictors of mortality in patients with Ebola virus disease. Clin. Infect. Dis. 2015; 60(12): 1821–4.CrossRefGoogle ScholarPubMed
Biava, M., Caglioti, C., Bordi, L., et al. Detection of viral RNA in tissues following plasma clearance from an Ebola virus infected patient. PLoS Pathog. 2017; 13(1): e1006065.CrossRefGoogle ScholarPubMed
Chertow, D. S., Kleine, C., Edwards, J. K., et al. Ebola virus disease in West Africa – clinical manifestations and management. N. Engl. J. Med. 2014; 371(22): 2054–7.CrossRefGoogle ScholarPubMed
Diallo, B., Sissoko, D., Loman, N. J., et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin. Infect. Dis. 2016; 63(10): 1353–6.CrossRefGoogle ScholarPubMed
Dye, C. and WHO Ebola Response Team. Ebola virus disease in West Africa – the first 9 months. N. Engl. J. Med. 2015; 372(2): 189.Google ScholarPubMed
Feldmann, H. Ebola – a growing threat? N. Engl. J. Med. 2014; 371(15): 1375–8.CrossRefGoogle ScholarPubMed
Feldmann, H. and Geisbert, T. W. Ebola haemorrhagic fever. Lancet 2011; 377(9768): 849–62.CrossRefGoogle ScholarPubMed
Henao-Restrepo, A. M., Camacho, A., Longini, I. M., et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2017; 389(10068): 505–18.CrossRefGoogle ScholarPubMed
Hunt, L., Gupta-Wright, A., Simms, V., et al. Clinical presentation, biochemical, and haematological parameters and their association with out-come in patients with Ebola virus disease: an observational cohort study. Lancet Infect. Dis. 2015; 15(11): 1292–9.CrossRefGoogle Scholar
Jacobs, M., Aarons, E., Bhagani, S., et al. Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers. Lancet Infect. Dis. 2015; 15(11): 1300–4.CrossRefGoogle ScholarPubMed
Lanini, S., Portella, G., Vairo, F., et al. Blood kinetics of Ebola virus in survivors and nonsurvivors. J. Clin. Invest. 2015; 125(12): 4692–8.CrossRefGoogle ScholarPubMed
Liddell, A. M., Davey, R. T. Jr., Mehta, A. K., et al. Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States. Ann. Intern. Med. 2015; 163(2): 8190.CrossRefGoogle ScholarPubMed
Lyon, G. M., Mehta, A. K., Varkey, B., et al. Emory Serious Communicable Diseases Unit. Clinical care of two patients with Ebola virus disease in the United States. N. Engl. J. Med. 2014; 371(25): 2402–9.CrossRefGoogle ScholarPubMed
Mate, S. E., Kugelman, J. R., Nyenswah, T. G., et al. Molecular evidence of sexual transmission of Ebola virus. N. Engl. J. Med. 2015; 373(25): 2448–54.CrossRefGoogle ScholarPubMed
PREVAIL II Writing Group, Multi-National PREVAIL II Study Team, Davey, R. T. Jr., et al. A randomized, controlled trial of ZMapp for Ebola virus infection. N. Engl. J. Med. 2016; 375(15): 1448–56.Google ScholarPubMed
Rodriguez, L. L., De Roo, A., Guimard, Y., et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 1999; 179(Suppl. 1): S170–6.CrossRefGoogle ScholarPubMed
Sands, P., Mundaca-Shah, C., and Dzau, V. J. The neglected dimension of global security – a framework for countering infectious-disease crises. N. Engl. J. Med. 2016; 374(13): 1281–7.CrossRefGoogle ScholarPubMed
Schieffelin, J. S., Shaffer, J. G., Goba, A., et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N. Engl. J. Med. 2014; 371(22): 2092–100.CrossRefGoogle ScholarPubMed
Tan, K. R., Cullen, K. A., Koumans, E. H., and Arguin, P. M. Inadequate diagnosis and treatment of malaria among travelers returning from Africa during the Ebola epidemic – United States, 2014–2015. MMWR Morb. Mortal. Wkly. Rep. 2016; 65(2): 27–9.CrossRefGoogle ScholarPubMed
Uyeki, T. M., Mehta, A. K., Davey, R. T., Jr., et al., Clinical management of Ebola virus disease in the United States and Europe. N. Engl. J. Med. 2016; 374(7): 636–46.CrossRefGoogle ScholarPubMed
Varkey, J. B., Shantha, J. G., Crozier, I., et al. Persistence of Ebola virus in ocular fluid during convalescence. N. Engl. J. Med. 2015; 372(25): 2423–7.CrossRefGoogle ScholarPubMed
Waxman, M., Aluisio, A. R., Rege, S., and Levine, A. C. Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study. Lancet Infect. Dis. 2017; 17(6): 654–60.CrossRefGoogle ScholarPubMed
WHO Ebola Response Team, Agua-Agum, J., Allegranzi, B., et al. After Ebola in West Africa – unpredictable risks, preventable epidemics. N. Engl. J. Med. 2016; 375(6): 587–96.Google ScholarPubMed
Wong, K. K., Davey, R. T., Jr., Hewlett, A. L., et al. Use of postexposure prophylaxis after occupational exposure to Zaire Ebolavirus. Clin. Infect. Dis. 2016; 63(3): 376–9.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×